0,975  0,001  Monophenol monooxygenase inhibitor
0,972  0,001  NOS2 expression inhibitor
0,956  0,002  AR expression inhibitor
0,936  0,001  Melanin inhibitor
0,938  0,003  Lipoxygenase inhibitor
0,918  0,003  CYP1A2 inhibitor
0,898  0,006  Transcription factor NF kappa B inhibitor
0,880  0,003  Chemopreventive
0,868  0,003  Skin whitener
0,866  0,009  Apoptosis agonist
0,857  0,003  Hypoxia-inducible factor 1 alpha inhibitor
0,838  0,004  Cytostatic
0,826  0,004  Antioxidant
0,819  0,002  Antihypotensive
0,803  0,006  15-Lipoxygenase inhibitor
0,803  0,007  CYP2C9 substrate
0,794  0,004  CYP2C19 substrate
0,786  0,004  CYP2C19 inhibitor
0,791  0,009  Antineoplastic (lung cancer)
0,783  0,002  NOS3 expression enhancer
0,774  0,008  Carcinogenic
0,763  0,004  NOS3 expression inhibitor
0,765  0,007  Radioprotector
0,767  0,020  Antiinflammatory
0,744  0,005  Antiosteoporotic
0,751  0,014  Antineoplastic (breast cancer)
0,741  0,005  Free radical scavenger
0,738  0,005  UGT1A9 substrate
0,732  0,005  CTGF expression inhibitor
0,731  0,005  Antineoplastic (glioma)
0,725  0,006  Bone diseases treatment
0,708  0,009  Chemoprotective
0,703  0,005  Nitric oxide antagonist
0,701  0,006  Antineoplastic (melanoma)
0,706  0,012  Antileukemic
0,698  0,006  Proliferative diseases treatment
0,679  0,005  UGT1A1 substrate
0,680  0,007  Spasmolytic
0,649  0,013  Antihypercholesterolemic
0,642  0,008  Antiparasitic
0,636  0,005  Antihelmintic
0,634  0,006  Antiprotozoal (Leishmania)
0,635  0,008  CYP2C9 inhibitor
0,645  0,019  Antineoplastic (colorectal cancer)
0,632  0,007  Antineoplastic (brain cancer)
0,620  0,004  Lipid peroxidase inhibitor
0,633  0,019  Antineoplastic (colon cancer)
0,617  0,009  Cardioprotectant
0,618  0,017  Antibacterial
0,602  0,003  Estrogen receptor alpha antagonist
0,594  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,591  0,004  Protein-tyrosine phosphatase inhibitor
0,598  0,016  Antineoplastic (ovarian cancer)
0,587  0,014  12-Lipoxygenase inhibitor
0,579  0,007  Vasodilator
0,578  0,008  Antiprotozoal (Trypanosoma)
0,560  0,011  Hypoglycemic
0,555  0,021  Streptokinase A inhibitor
0,563  0,032  CYP3A4 substrate
0,545  0,015  Caspase 3 stimulant
0,584  0,057  Alpha-glucosidase inhibitor
0,529  0,006  UGT1A3 substrate
0,531  0,009  Antihypertriglyceridemic
0,539  0,018  Antineoplastic (cervical cancer)
0,537  0,019  CYP1A2 substrate
0,518  0,002  Papain-like protease (SARS coronavirus) inhibitor
0,538  0,026  Prostate cancer treatment
0,505  0,010  RNA-directed DNA polymerase inhibitor
0,508  0,020  Hepatic disorders treatment
0,490  0,015  Antineoplastic (glioblastoma multiforme)
0,506  0,032  Aldehyde oxidase inhibitor
0,493  0,021  Apoptosis antagonist
0,481  0,013  Vascular (periferal) disease treatment
0,464  0,009  Hepatoprotectant
0,477  0,023  Mutagenic
0,456  0,009  Carcinogenic, group 3
0,460  0,013  Myocardial infarction treatment
0,446  0,008  Platelet adhesion inhibitor
0,451  0,015  UDP-glucuronosyltransferase substrate
0,482  0,051  TNF expression inhibitor
0,438  0,009  Bone formation stimulant
0,467  0,042  Histamine release inhibitor
0,444  0,020  DNA damaging
0,478  0,057  Cyclophilin D inhibitor
0,478  0,057  Antidiabetic
0,452  0,031  Antifungal
0,422  0,004  Heat shock protein 90 antagonist
0,421  0,005  Breast cancer-resistant protein inhibitor
0,431  0,026  Cardiovascular analeptic
0,434  0,031  Antimycobacterial
0,406  0,005  5-Lipoxygenase inhibitor
0,445  0,048  Immunosuppressant
0,449  0,069  Alzheimer's disease treatment
0,435  0,055  Antiprotozoal
0,406  0,031  CYP3A4 inhibitor
0,407  0,037  ICAM1 expression inhibitor
0,370  0,004  Electron transport complex I inhibitor
0,372  0,012  Topoisomerase II inhibitor
0,386  0,027  Antineoplastic (renal cancer)
0,396  0,039  Antineoplastic (pancreatic cancer)
0,377  0,024  Antiulcerative
0,363  0,014  MAO inhibitor
0,377  0,028  UGT1A6 substrate
0,386  0,038  Cytotoxic
0,390  0,046  Respiratory analeptic
0,379  0,037  Antineoplastic (non-small cell lung cancer)
0,344  0,005  Estrogen receptor beta antagonist
0,382  0,043  Lipoprotein disorders treatment
0,368  0,030  Antineoplastic (osteosarcoma)
0,385  0,047  CYP2D6 substrate
0,333  0,005  Phosphodiesterase 4D inhibitor
0,355  0,028  Antineoplastic (lymphocytic leukemia)
0,370  0,046  Vasodilator, coronary
0,326  0,005  Estrogen antagonist
0,330  0,010  Heat shock protein 90 alpha antagonist
0,329  0,018  Mcl-1 antagonist
0,321  0,025  P-glycoprotein inhibitor
0,302  0,007  Xanthine oxidase inhibitor
0,298  0,007  Dementia treatment
0,295  0,007  Vascular dementia treatment
0,318  0,044  Antineoplastic (liver cancer)
0,282  0,010  Antihemorrhagic
0,287  0,016  MAO A inhibitor
0,274  0,003  SULT1E1 substrate
0,274  0,005  Postmenopausal disorders treatment
0,387  0,119  Caspase 9 stimulant
0,271  0,004  Phosphodiesterase VI inhibitor
0,364  0,096  Antiparkinsonian
0,313  0,047  Antidiabetic symptomatic
0,289  0,023  Antineoplastic (squamous cell carcinoma)
0,314  0,052  Sensitization
0,262  0,004  Lipase inhibitor
0,263  0,006  Estrogen agonist
0,259  0,004  Ornithine decarboxylase inhibitor
0,314  0,060  Antituberculosic
0,264  0,018  Acetylcholinesterase inhibitor
0,271  0,028  Neurotrophic factor enhancer
0,291  0,050  Pyruvate kinase inhibitor
0,259  0,020  Cyclooxygenase 1 inhibitor
0,238  0,004  Neuraminidase inhibitor
0,274  0,043  Antineoplastic enhancer
0,241  0,011  Topoisomerase II alpha inhibitor
0,296  0,069  Antineoplastic (multiple myeloma)
0,244  0,021  Antidiarrheal
0,287  0,065  Aryl hydrocarbon receptor agonist
0,257  0,036  Diabetic retinopathy treatment
0,235  0,015  Neurotrophic factor
0,295  0,078  Analeptic
0,235  0,023  Alkaline phosphatase inhibitor
0,282  0,072  Antihypoxic
0,232  0,024  Antineoplastic (bone cancer)
0,216  0,008  ABCA1 expression enhancer
0,236  0,032  Amylase inhibitor
0,230  0,026  Genotoxic
0,227  0,027  VEGF expression inhibitor
0,212  0,012  Carbonic anhydrase XIII inhibitor
0,231  0,032  UGT2B15 substrate
0,239  0,041  Antimutagenic
0,280  0,086  Antiischemic
0,271  0,077  Antidiabetic (type 2)
0,258  0,066  Angiogenesis stimulant
0,193  0,005  Neuraminidase (influenza) inhibitor
0,208  0,020  Butyrylcholinesterase inhibitor
0,212  0,034  Tubulin antagonist
0,203  0,026  Topoisomerase I inhibitor
0,191  0,014  Beta glucuronidase inhibitor
0,227  0,050  CYP2B6 inhibitor
0,179  0,004  Fatty acid synthase inhibitor
0,213  0,040  Antineoplastic (carcinoma)
0,195  0,022  Antineoplastic antibiotic
0,186  0,014  Alcohol dehydrogenase inhibitor
0,247  0,076  Tumour necrosis factor alpha release inhibitor
0,177  0,012  NAD(P)H dehydrogenase (quinone) inhibitor
0,240  0,077  Antineoplastic (sarcoma)
0,203  0,041  Cyclooxygenase inhibitor
0,170  0,008  Interleukin 5 antagonist
0,238  0,077  Antiamyloidogenic
0,204  0,045  Cholinergic
0,220  0,062  Wound healing agent
0,184  0,027  Antibacterial (Helicobacter pylori)
0,184  0,028  MAO B inhibitor
0,185  0,032  CF transmembrane conductance regulator agonist
0,229  0,078  Hypolipemic
0,153  0,003  Transcription factor RelA inhibitor
0,262  0,114  Angiogenesis inhibitor
0,218  0,077  Antiviral (HIV)
0,151  0,013  Peroxisome proliferator-activated receptor gamma agonist
0,265  0,130  Ulceration
0,148  0,013  Aromatase inhibitor
0,195  0,064  UGT2B7 substrate
0,168  0,037  Cholesterol synthesis inhibitor
0,181  0,053  Antiviral (Influenza A)
0,179  0,055  Arachidonic acid antagonist
0,198  0,076  Pneumotoxic
0,153  0,031  Contraceptive female
0,198  0,079  Amyloid beta aggregation inhibitor
0,293  0,173  5 Hydroxytryptamine release inhibitor
0,195  0,078  Antiviral (Influenza)
0,227  0,109  UGT2B4 substrate
0,195  0,078  Insulin sensitizer
0,121  0,005  Potassium channel Kv1.3 blocker
0,206  0,091  Teratogen
0,158  0,044  Farnesoid X receptor antagonist
0,141  0,027  DOPA decarboxylase inhibitor
0,191  0,078  Abortion inducer
0,148  0,039  Gastritis treatment
0,119  0,011  Ca(v)3.1 blocker
0,112  0,007  Estrogen receptor alpha agonist
0,164  0,059  Protein kinase stimulant
0,206  0,104  Antiviral (West Nile virus)
0,118  0,017  Na+ K+ transporting ATPase inhibitor
0,236  0,135  Cholesterol antagonist
0,119  0,020  HIV-1 integrase (3'-Processing) inhibitor
0,172  0,072  UGT1A4 substrate
0,110  0,010  Estrogen receptor beta agonist
0,102  0,004  Retinoic acid alpha receptor agonist
0,157  0,060  Antiprotozoal (Coccidial)
0,172  0,076  Male reproductive disfunction treatment
0,148  0,052  Antiprotozoal (Trichomonas)
0,139  0,046  Antineoplastic (uterine cancer)
0,151  0,059  MAP kinase kinase 4 inhibitor
0,130  0,039  Sulfotransferase substrate
0,093  0,005  Retinoid X receptor agonist
0,204  0,118  Immunostimulant
0,104  0,021  HIV-1 integrase (Strand Transfer) inhibitor
0,131  0,048  Carcinogenic, group 2B
0,142  0,060  Cyclooxygenase 2 inhibitor
0,155  0,073  Diuretic
0,138  0,056  Aldehyde dehydrogenase inhibitor
0,135  0,054  Coagulant
0,204  0,123  Huntington's disease treatment
0,179  0,101  Embryotoxic
0,121  0,044  Urease inhibitor
0,108  0,031  Inducible nitric-oxide synthase inhibitor
0,119  0,044  Antiviral (Coronavirus)
0,119  0,044  Antiviral (SARS coronavirus)
0,203  0,128  Antineoplastic (bladder cancer)
0,127  0,055  Alcohol dehydrogenase substrate
0,173  0,101  Interleukin antagonist
0,189  0,118  MAP-kinase-activated kinase 5 inhibitor
0,109  0,039  Thioredoxin inhibitor
0,077  0,008  Pregnane X receptor antagonist
0,181  0,114  VCAM1 expression inhibitor
0,090  0,023  Peroxisome proliferator-activated receptor gamma antagonist
0,146  0,081  Antiviral (Herpes)
0,136  0,071  Antifungal enhancer
0,086  0,021  Androgen agonist
0,179  0,114  Antineoplastic (lymphoma)
0,091  0,030  HIV-1 integrase inhibitor
0,115  0,055  Gout treatment
0,142  0,083  Insulin secretagoues
0,224  0,166  Antiprotozoal (Plasmodium)
0,090  0,034  CDC25A inhibitor
0,141  0,085  Phospholipase A2 inhibitor
0,169  0,114  Histone acetyltransferase inhibitor
0,080  0,028  CDC25B inhibitor
0,126  0,076  NADPH oxidase inhibitor
0,071  0,021  Peroxisome proliferator-activated receptor alpha agonist
0,177  0,129  Antipyretic
0,105  0,058  Bronchodilator
0,086  0,042  Antibiotic
0,046  0,007  Estrogen-related receptor beta antagonist
0,080  0,042  Histidine decarboxylase inhibitor
0,057  0,021  Carbonic anhydrase VII inhibitor
0,134  0,098  UGT2B9 substrate
0,140  0,106  Interleukin 6 antagonist
0,119  0,086  Contraceptive
0,100  0,068  Expectorant
0,078  0,048  SULT1A2 substrate
0,139  0,108  Dual specificity phosphatase inhibitor
0,065  0,035  Xanthine dehydrogenase inhibitor
0,079  0,050  CYP2A6 inhibitor
0,060  0,032  Aldose reductase inhibitor
0,034  0,008  Retinoic acid receptor agonist
0,128  0,103  Antifungal (Cryptococcus)
0,083  0,058  Phosphodiesterase IV inhibitor
0,043  0,019  Retinoid X receptor antagonist
0,093  0,070  UGT2B11 substrate
0,104  0,082  DNA polymerase I inhibitor
0,143  0,122  Phospholipase C inhibitor
0,141  0,120  UGT2B10 substrate
0,099  0,079  Chelator
0,093  0,073  Anabolic
0,036  0,016  Liver X receptor antagonist
0,205  0,186  GST M1-1 substrate
0,103  0,085  Beta amyloid protein antagonist
0,037  0,019  Retinoid X alpha receptor antagonist
0,038  0,021  Retinoid X alpha receptor agonist
0,210  0,197  Antiobesity
0,101  0,089  Aldehyde dehydrogenase substrate
0,040  0,028  Cathepsin L2 inhibitor
0,100  0,088  Photosensitizer
0,063  0,051  Leukotriene synthesis inhibitor
0,115  0,105  Peroxidase inhibitor
0,024  0,014  Peroxisome proliferator-activated receptor alpha antagonist
0,033  0,023  Peroxisome proliferator-activated receptor delta antagonist
0,098  0,091  TRPA1 agonist
0,062  0,056  Potassium channel large-conductance Ca-activated activator
0,020  0,014  Inosine monophosphate dehydrogenase 1 inhibitor
0,026  0,021  Toll-Like receptor 4 agonist
0,046  0,042  Cytokine production stimulant
0,047  0,044  Factor III inhibitor
0,093  0,090  SULT1A1 substrate
0,047  0,045  Glucose-6-phosphate translocase inhibitor

